Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin αvβ3) antagonists
摘要:
In our continuing efforts to identify small molecule vitronectin receptor antagonists, we have discovered a series of phenylbutyrate derivatives, exemplified by 16, which have good potency and excellent oral bioavailability (approximately 100% in rats). This new series is derived conceptually from opening of the seven-membered ring of SB-265123. (C) 2003 Elsevier Science Ltd. All rights reserved.